International normalised ratio (INR) measured on the CoaguChek S and XS compared with the laboratory for determination of precision and accuracy

Thrombosis and Haemostasis

Volumn 101, Issue 3, 2009, Pages 563-569

  Christensen, Thomas D ^a   Larsen, Torben B ^b   Jensen, Claus ^c   Maegaard, Marianne ^a   Sørensen, Benny ^a,d  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c Danish Comp Ctr for Res and Educ   (Denmark)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Coumarins; International normalised ratio; Oral anticoagulant; Point of care testing; Self management

Indexed keywords

ACETYLSALICYLIC ACID; COUMARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; AORTA VALVE PROSTHESIS; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE; DIAGNOSTIC ACCURACY; DRUG MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; MALE; PRIORITY JOURNAL; THROMBOSIS;

AGED; ANTICOAGULANTS; COUMARINS; DRUG MONITORING; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; SELF ADMINISTRATION; SENSITIVITY AND SPECIFICITY;

EID: 62549119556     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-09-0601     Document Type: Article

References (30)

1. Hirsh J, Dalen J, Anderson DR, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 2001; 119: 8S-21S.
2. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, et al. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet 2006; 367: 404-411.
3. Christensen TD, Johnsen SP, Hjortdal VE, et al. Self-management of oral anticoagulant therapy: a systematic review and meta-analysis, Int J Cardiol 2007; 118: 54-61.
4. Van den Besselaar AM. Accuracy, precision, and quality control for point-of-care testing of oral anticoagulation. J Thromb Thrombolysis 2001; 12: 35-40.
5. Tripodi A, Chantarangkul V, Mannucci P. Near-patient testing devices to monitor oral anticoagulant therapy. Br J Haematol 2001; 113: 847-852.
6. Fairweather KB, Ansell J, Van den Besselaar AM. et al. College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of oral anticoagulant therapy. Arch Pathol Lab Med 1998; 122: 768-781.
7. Attermann J, Kynde K, Hasenkam JM. Precision of patients' measurements of the international normalized ratio (INR) using a patient operated whole blood home coagulometer. Thromb Res 1998; 92: 287-291.
8. Hillarp A, Egberg N, Nordin G, et al. Local INR calibration of the Owren type prothrombin assay greatly improves the intra- and interlaboratory variation. A three-year follow-up from the Swedish national external quality assessment scheme. Thromb Haemosl 2004; 91: 300-307.
9. Bruns DE, Huth EJ, Magid E, et al. Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem 2000; 46: 893-895.
10. van den Besselar AM. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-412.
11. Kjeldsen J, Lassen JF, Petersen PH, et al. Biological variation of International Normalized Ratio for prothrombin times, and consequences in monitoring oral anticoagulant therapy: computer simulation of serial measurements with goal-setting for analytical quality. Clin Chem 1997; 43: 2175-2182.
12. Anderson DR, Harrison L, Hirsh J. Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. Arch Intern Med 1993; 153: 1441-1447.
13. Douketis JD, Lane A, Milne J, et al. Accuracy of a portable International Normalization Ratio monitor in outpatients receiving long-term oral anticoagulant therapy: comparison with a laboratory reference standard using clinically relevant criteria for agreement. Thromb Res 1998; 92: 11-17.
14. Poller L, Keown M, Ibrahim SA, et al. Quality assessment of CoaguChek point-of-care prothrombin time monitors: comparison of the European community-approved procedure and conventional external quality assessment. Clin Chem 2006; 52: 1843-1847.
15. Christensen TD. Self-management of oral anticoagulant therapy: a review. J Thromb Thrombolysis 2004; 18: 127-143.
16. Bland JM, Altaian DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
17. Cromheecke ME, Levi M, Colly LP, et al. Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised crossover comparison. Lancet 2000; 356: 97-102.
18. Hasenkam JM, Kimose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardiothorac Surg 1997; 11: 935-942.
19. Kortke H, Körfer R. International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 72: 44-48.
20. Sawicki PL A structured teaching and self-management program for patients receiving oral anticoagulation: a randomized controlled trial. Working Group for the Study of Patient Self-Management of Oral Anticoagulation. J Am Med Assoc 1999; 281: 145-150.
21. Watzke HH, Forberg E, Svolba G, et al. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation. Thromb Haemost 2000; 83: 661-665.
22. Braun S, Watzke 11, Hasenkam JM, et al. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management. Thromb Haemost 2007; 97: 310-314.
23. Guide-lines for near patient testing: haematology. Near Patient Testing Working Party. General Haematology Task Force of BCSH. Thrombosis and Haemostasis Task Force of BCSH. Clin Lab Haematol 1995; 17: 301-310.
24. Williams VK, Griffiths AB. Acceptability of CoaguChek S and CoaguChek XS generated international normalised ratios against a laboratory standard in a paediatnc setting. Pathology 2007; 39: 575-579.
25. Nam MH, Roh KH, Pak HN, et al. Evaluation of the Roche CoaguChek XS handheld coagulation analyzer in a cardiac outpatient clinic. Ann Clin Lab Sci 2008; 38: 37-10.
26. Bauman ME, Black KL, Massicotte MP, et al. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin. Thromb Haemost 2008; 99: 1097-1103.
27. Karon BS, McBane RD, Chaudhry R, et al. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers. Am J Clin Pathol 2008; 130: 88-92.
28. Bereznicki LR, Jackson SL, Peterson GM, et al. Accuracy and clinical utility of the CoaguChek XS portable international normalised ratio monitor in a pilot study of warfarin home-monitoring. J Clin Pathol 2007; 60: 311-314.
29. Van den Besselaar AM, Barrowcliffe TW, Houbouyan-Reveillard LL, et al. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost 2004; 2: 1946-1953.
30. Cannegieter SC, Rosendaal FR, Wintzen AR, et al. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med 1995; 333: 11-17.